AI Screening AI Chat Pricing

Daito Pharmaceutical Co., Ltd.【JP:4577】Income statement

Market cap

¥43.5B

P/E ratio

18.8x

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2012/05	2013/05	2014/05	2015/05	2016/05	2017/05	2018/05	2019/05	2020/05	2021/05	2022/05	2023/05	2024/05	2025/05
Revenue	27,151	28,956	31,196	34,059	36,371	37,984	39,876	41,135	44,991	48,715	43,464	45,101	46,895	50,643
Revenue growth (%)	-
Cost of revenue	-	-	-	26,990	29,104	30,232	31,765	32,463	35,513	37,917	32,005	34,770	37,056	42,005
Gross profit	-	-	-	7,068	7,266	7,752	8,111	8,671	9,479	10,798	11,458	10,331	9,839	8,637
Gross margin (%)	-	-	-
Operating margin (%)	-	-	-
Operating expenses	-	-	-	3,553	3,671	3,909	3,957	4,124	4,127	4,883	4,905	5,123	5,945	6,017
Operating income	-	-	-	3,519	3,556	3,832	4,161	4,547	5,357	5,909	6,553	5,207	3,894	2,619
Income before tax	2,572	2,541	2,921	3,453	3,714	3,879	4,244	4,642	5,463	6,068	6,729	5,169	3,923	2,705
Pretax margin (%)	9.5	8.8	9.4	10.1	10.2	10.2	10.6	11.3	12.1	12.5	15.5	11.5	8.4	5.3
Provision for income taxes	-	-	-	1,136	879	1,258	1,251	1,122	1,670	1,717	2,092	1,549	1,040	1,192
Effective tax rate (%)	-	-	-
Net income	1,149	1,511	1,560	2,246	2,566	2,656	3,042	3,513	3,945	4,246	4,668	3,600	3,295	1,908
Net income margin (%)
Earnings per share	155.1	194.13	166.58	183.51	205.07	212.26	243.08	280.73	309.66	311.02	335.41	250.39	210	62.74
Diluted EPS	-	-	-	-	-	-	-	-	307.44	-	-	250.17	-	-
Dividend payout ratio (%)	-	-	-	-	-	-	-	-		-	-		-	-
Dividend per share	-	-	-	-	-	-	-	-	46	46	60	60	60	70
EBITDA	-	-	-
EBITDA margin (%)	-	-	-

Raw aggregated data